Home 2018-12-13T23:50:36+00:00

Working together to accelerate patient access to advanced therapies

the attc network
attc network coverage

Three centres: One network

At sites across the UK, the NHS and industry are working to provide ready to use systems and solutions to accelerate adoption of advanced therapies

  • iMATCH
  • Midlands – Wales
  • Northern Alliance

Coordinated by Cell and Gene Therapy Catapult

iMATCH is a Manchester based consortium focused on the scale-up of activity in ATMPs. We aim to improve patient access to ATMPs whilst ensuring safe and efficient delivery.
Key objectives

  • To maximise access of ATMP to patients through integration of sample collection
  • To develop electronic sample traceability and tracking systems through novel digital solutions
  • To develop innovative systems of clinical data capture for ATMPs
  • To ensure safe delivery of ATMPs through education, communication and dissemination

Visit this centre

The Midlands and Wales Advanced Therapy Treatment Centre (MW-ATTC) consists of a large regional network with the necessary commercial and NHS infrastructure required to facilitate the delivery of advanced therapy treatments to patients.

Key objectives

  • Programme Management
  • Clinical Delivery
  • Logistics
  • Manufacture
  • Economic Evaluation
  • Informatics

Visit this centre

The Northern Alliance Advanced Therapies Treatment Centre (NAATTC), formally established in March 2018, is a consortium of twenty industry, NHS and academic organisations led by Newcastle Hospitals and SNBTS.

Key objectives

  • Identify all areas for improvement through gap analysis
  • Design, devise and implement solutions in these areas
  • Ensure that solutions are integrated across the clinical delivery pathway
  • Roll out and disseminate best practice regionally and nationally.

Visit this centre